ACOG says no to hormone therapy for heart disease prevention

05/24/2013 | PhysiciansBriefing.com

The American College of Obstetricians and Gynecologists issued a committee opinion advising against the use of menopausal hormone therapy for primary or secondary prevention of coronary heart disease. The group said there is not enough evidence linking long-term estrogen treatment or hormone therapy to improved cardiovascular outcomes. "As with younger women, use of hormone therapy and estrogen therapy should be individualized based on each woman's risk-benefit ratio and clinical presentation," ACOG said in the journal Obstetrics & Gynecology.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC